{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:49:57Z","timestamp":1784771397441,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute liver failure (ALF) is a deadly illness due to insufficient detoxification in liver induced by drugs, toxins, and other etiologies, and the effective treatment for ALF is very limited. Among the drug-induced ALF, acetaminophen (APAP) overdose is the most common cause. However, the molecular mechanisms underlying APAP hepatoxicity remain incompletely understood. Sirtuin 6 (Sirt6) is a stress responsive protein deacetylase and plays an important role in regulation of DNA repair, genomic stability, oxidative stress, and inflammation. Here, we report that genetic and pharmacological activation of Sirt6 protects against ALF in mice. We first observed that Sirt6 expression was significantly reduced in the liver tissues of human patients with ALF and mice treated with an overdose of APAP. Then we developed an inducible Sirt6 transgenic mice for Cre-mediated overexpression of the human Sirt6 gene in systemic (Sirt6-Tg) and hepatic-specific (Sirt6-HepTg) manners. Both Sirt6-Tg mice and Sirt6-HepTg mice exhibited the significant protection against APAP hepatoxicity. In contrast, hepatic-specific Sirt6 knockout mice exaggerated APAP-induced liver damages. Mechanistically, Sirt6 attenuated APAP-induced hepatocyte necrosis and apoptosis through downregulation of oxidative stress, inflammation, the stress-activated kinase JNK activation, and apoptotic caspase activation. Moreover, Sirt6 negatively modulated the level and activity of poly (ADP-ribose) polymerase 1 (PARP1) in APAP-treated mouse liver tissues. Importantly, the specific Sirt6 activator MDL-800 exhibited better therapeutic potential for APAP hepatoxicity than the current drug acetylcysteine. Furthermore, in the model of bile duct ligation induced ALF, hepatic Sirt6-KO exacerbated, but Sirt6-HepTg mitigated liver damage. Collectively, our results demonstrate that Sirt6 protects against ALF and suggest that targeting Sirt6 activation could be a new therapeutic strategy to alleviate ALF.<\/jats:p>","DOI":"10.1038\/s41419-024-06537-5","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T16:02:36Z","timestamp":1713801756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatic Sirt6 activation abrogates acute liver failure"],"prefix":"10.1038","volume":"15","author":[{"given":"Jinque","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebbeca A.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4422-6848","authenticated-orcid":false,"given":"Shuyi","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8367-5526","authenticated-orcid":false,"given":"Zheng Gen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"6537_CR1","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1056\/NEJMra1208937","volume":"369","author":"W Bernal","year":"2013","unstructured":"Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369:2525\u201334.","journal-title":"N Engl J Med"},{"key":"6537_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MCC.0000000000000923","volume":"28","author":"F Vasques","year":"2022","unstructured":"Vasques F, Cavazza A, Bernal W. Acute liver failure. Curr Opin Crit care. 2022;28:198\u2013207.","journal-title":"Curr Opin Crit care"},{"key":"6537_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/17511437211007777","volume":"23","author":"MA Arshad","year":"2022","unstructured":"Arshad MA, Bangash MN. Acute liver failure following paracetamol overdose. J Intensive Care Soc. 2022;23:244\u201351.","journal-title":"J Intensive Care Soc"},{"key":"6537_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-0042-1755274","volume":"42","author":"S Tujios","year":"2022","unstructured":"Tujios S, Stravitz RT, Lee WM. Management of acute liver failure: update 2022. Semin Liver Dis. 2022;42:362\u201378.","journal-title":"Semin Liver Dis"},{"key":"6537_CR5","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.jhepr.2020.100149","volume":"2","author":"MN Rahim","year":"2020","unstructured":"Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep. 2020;2:100149.","journal-title":"JHEP Rep"},{"key":"6537_CR6","first-page":"S3","volume":"38","author":"WM Lee","year":"2008","unstructured":"Lee WM. Acetaminophen-related acute liver failure in the United States. Hepatol Res. 2008;38:S3\u20138.","journal-title":"Hepatol Res"},{"key":"6537_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1586\/17474124.2015.1060855","volume":"9","author":"BL Woolbright","year":"2015","unstructured":"Woolbright BL, Jaeschke H. Sterile inflammation in acute liver injury: myth or mystery? Expert Rev Gastroenterol Hepatol 2015;9:1027\u20139.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"6537_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cld.2018.01.007","volume":"22","author":"C Bunchorntavakul","year":"2018","unstructured":"Bunchorntavakul C, Reddy KR. Acetaminophen (APAP or N-Acetyl-p-aminophenol) and acute liver failure. Clin Liver Dis. 2018;22:325\u201346.","journal-title":"Clin Liver Dis"},{"key":"6537_CR9","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1172\/JCI59755","volume":"122","author":"MR McGill","year":"2012","unstructured":"McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Investig. 2012;122:1574\u201383.","journal-title":"J Clin Investig"},{"key":"6537_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/03602532.2020.1832112","volume":"52","author":"MR McGill","year":"2020","unstructured":"McGill MR, Hinson JA. The development and hepatotoxicity of acetaminophen: reviewing over a century of progress. Drug Metab Rev. 2020;52:472\u2013500.","journal-title":"Drug Metab Rev"},{"key":"6537_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","volume":"17","author":"M Yan","year":"2018","unstructured":"Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol. 2018;17:274\u201383.","journal-title":"Redox Biol"},{"key":"6537_CR12","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/cells11172620","volume":"11","author":"S Kumar","year":"2022","unstructured":"Kumar S, Singla B, Singh AK, Thomas-Gooch SM, Zhi K, Singh UP. Hepatic, extrahepatic and extracellular vesicle cytochrome P450 2E1 in alcohol and acetaminophen-mediated adverse interactions and potential treatment options. Cells. 2022;11:2620.","journal-title":"Cells"},{"key":"6537_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00204-014-1432-2","volume":"89","author":"EM Lancaster","year":"2015","unstructured":"Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89:193\u20139.","journal-title":"Arch Toxicol"},{"key":"6537_CR14","first-page":"131","volume":"4","author":"E Yoon","year":"2016","unstructured":"Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 2016;4:131\u201342.","journal-title":"J Clin Transl Hepatol"},{"key":"6537_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1159\/000374090","volume":"33","author":"H Jaeschke","year":"2015","unstructured":"Jaeschke H. Acetaminophen: dose-dependent drug hepatotoxicity and acute liver failure in patients. Digestive Dis. 2015;33:464\u201371.","journal-title":"Digestive Dis"},{"key":"6537_CR16","first-page":"170","volume":"3","author":"BL Woolbright","year":"2017","unstructured":"Woolbright BL, Jaeschke H. The impact of sterile inflammation in acute liver injury. J Clin Transl Res. 2017;3:170\u201388.","journal-title":"J Clin Transl Res"},{"key":"6537_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1755-1536-6-19","volume":"6","author":"C Liedtke","year":"2013","unstructured":"Liedtke C, Luedde T, Sauerbruch T, Scholten D, Streetz K, Tacke F, et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenes Tissue Repair. 2013;6:19.","journal-title":"Fibrogenes Tissue Repair"},{"key":"6537_CR18","doi-asserted-by":"publisher","first-page":"41903","DOI":"10.1074\/jbc.M112.415182","volume":"287","author":"C Xiao","year":"2012","unstructured":"Xiao C, Wang RH, Lahusen TJ, Park O, Bertola A, Maruyama T, et al. Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J Biol Chem. 2012;287:41903\u201313.","journal-title":"J Biol Chem"},{"key":"6537_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/15384101.2016.1152427","volume":"15","author":"N Zhang","year":"2016","unstructured":"Zhang N, Li Z, Mu W, Li L, Liang Y, Lu M, et al. Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-kappaB signaling. Cell Cycle. 2016;15:1009\u201318.","journal-title":"Cell Cycle"},{"key":"6537_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature10815","volume":"483","author":"Y Kanfi","year":"2012","unstructured":"Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012;483:218\u201321.","journal-title":"Nature"},{"key":"6537_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","volume":"12","author":"HS Kim","year":"2010","unstructured":"Kim HS, Xiao C, Wang RH, Lahusen T, Xu X, Vassilopoulos A, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010;12:224\u201336.","journal-title":"Cell Metab"},{"key":"6537_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jhep.2019.06.019","volume":"71","author":"HG Kim","year":"2019","unstructured":"Kim HG, Huang M, Xin Y, Zhang Y, Zhang X, Wang G, et al. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice. J Hepatol. 2019;71:960\u20139.","journal-title":"J Hepatol"},{"key":"6537_CR23","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/hep.30062","volume":"68","author":"P Luo","year":"2018","unstructured":"Luo P, Qin C, Zhu L, Fang C, Zhang Y, Zhang H, et al. Ubiquitin-specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology. 2018;68:1786\u2013803.","journal-title":"Hepatology"},{"key":"6537_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep17602","volume":"5","author":"Y Wu","year":"2015","unstructured":"Wu Y, Chen L, Wang Y, Li W, Lin Y, Yu D, et al. Overexpression of Sirtuin 6 suppresses cellular senescence and NF-kappaB mediated inflammatory responses in osteoarthritis development. Sci Rep. 2015;5:17602.","journal-title":"Sci Rep"},{"key":"6537_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.apsb.2020.06.016","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Fan X, Jiao T, Li W, Chen P, Jiang Y, et al. SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation. Acta Pharm Sin B. 2021;11:89\u201399.","journal-title":"Acta Pharm Sin B"},{"key":"6537_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0039-1679919","volume":"39","author":"A Ramachandran","year":"2019","unstructured":"Ramachandran A, Jaeschke H. Acetaminophen hepatotoxicity. Semin Liver Dis. 2019;39:221\u201334.","journal-title":"Semin Liver Dis"},{"key":"6537_CR27","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.fct.2018.06.025","volume":"118","author":"H Jaeschke","year":"2018","unstructured":"Jaeschke H, Duan L, Akakpo JY, Farhood A, Ramachandran A. The role of apoptosis in acetaminophen hepatotoxicity. Food Chem Toxicol. 2018;118:709\u201318.","journal-title":"Food Chem Toxicol"},{"key":"6537_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2016.11.009","volume":"101","author":"L Wang","year":"2016","unstructured":"Wang L, Zhang S, Cheng H, Lv H, Cheng G, Ci X. Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK\/Akt\/GSK3\u03b2 pathway. Free Radic Biol Med. 2016;101:401\u201312.","journal-title":"Free Radic Biol Med."},{"key":"6537_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-018-0875-4","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Xu W, Zhang Y, Huang D, Huang K. Poly(ADP-ribosyl)ated PXR is a critical regulator of acetaminophen-induced hepatotoxicity. Cell Death Dis. 2018;9:819.","journal-title":"Cell Death Dis"},{"key":"6537_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.18632\/aging.100389","volume":"3","author":"M Van Meter","year":"2011","unstructured":"Van Meter M, Mao Z, Gorbunova V, Seluanov A. Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. Aging. 2011;3:829\u201335.","journal-title":"Aging"},{"key":"6537_CR31","doi-asserted-by":"publisher","first-page":"40924","DOI":"10.1074\/jbc.M112.405837","volume":"287","author":"I Bauer","year":"2012","unstructured":"Bauer I, Grozio A, Lasiglie D, Basile G, Sturla L, Magnone M, et al. The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J Biol Chem. 2012;287:40924\u201337.","journal-title":"J Biol Chem"},{"key":"6537_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1101\/gad.183509.111","volume":"26","author":"X Luo","year":"2012","unstructured":"Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012;26:417\u201332.","journal-title":"Genes Dev."},{"key":"6537_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41589-018-0150-0","volume":"14","author":"Z Huang","year":"2018","unstructured":"Huang Z, Zhao J, Deng W, Chen Y, Shang J, Song K, et al. Identification of a cellularly active SIRT6 allosteric activator. Nat Chem Biol. 2018;14:1118\u201326.","journal-title":"Nat Chem Biol"},{"key":"6537_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00204-021-03211-z","volume":"96","author":"JY Akakpo","year":"2022","unstructured":"Akakpo JY, Ramachandran A, Curry SC, Rumack BH, Jaeschke H. Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose. Arch Toxicol. 2022;96:453\u201365.","journal-title":"Arch Toxicol"},{"key":"6537_CR35","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/hep.29079","volume":"65","author":"L Hargrove","year":"2017","unstructured":"Hargrove L, Kennedy L, Demieville J, Jones H, Meng F, DeMorrow S, et al. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit(W-sh) mice. Hepatology. 2017;65:1991\u20132004.","journal-title":"Hepatology"},{"key":"6537_CR36","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s00204-019-02597-1","volume":"93","author":"H Jaeschke","year":"2019","unstructured":"Jaeschke H, Ramachandran A, Chao X, Ding WX. Emerging and established modes of cell death during acetaminophen-induced liver injury. Arch Toxicol. 2019;93:3491\u2013502.","journal-title":"Arch Toxicol"},{"key":"6537_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.taap.2014.05.010","volume":"279","author":"Y Xie","year":"2014","unstructured":"Xie Y, McGill MR, Dorko K, Kumer SC, Schmitt TM, Forster J, et al. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol. 2014;279:266\u201374.","journal-title":"Toxicol Appl Pharmacol"},{"key":"6537_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","volume":"10","author":"K Du","year":"2016","unstructured":"Du K, Ramachandran A, Jaeschke H. Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential. Redox Biol. 2016;10:148\u201356.","journal-title":"Redox Biol"},{"key":"6537_CR39","first-page":"331","volume":"3","author":"O Krenkel","year":"2014","unstructured":"Krenkel O, Mossanen JC, Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr. 2014;3:331\u201343.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"6537_CR40","first-page":"4134","volume":"127","author":"DL Douglas","year":"2014","unstructured":"Douglas DL, Baines CP. PARP1-mediated necrosis is dependent on parallel JNK and Ca(2)(+)\/calpain pathways. J Cell Sci. 2014;127:4134\u201345.","journal-title":"J Cell Sci"},{"key":"6537_CR41","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1128\/MCB.00160-13","volume":"33","author":"C Wang","year":"2013","unstructured":"Wang C, Zhang F, Wang L, Zhang Y, Li X, Huang K, et al. Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor alpha. Mol Cell Biol. 2013;33:4492\u2013503.","journal-title":"Mol Cell Biol"},{"key":"6537_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.18632\/aging.100975","volume":"8","author":"S Xu","year":"2016","unstructured":"Xu S, Yin M, Koroleva M, Mastrangelo MA, Zhang W, Bai P, et al. SIRT6 protects against endothelial dysfunction and atherosclerosis in mice. Aging. 2016;8:1064\u201382.","journal-title":"Aging"},{"key":"6537_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ajpath.2013.11.008","volume":"184","author":"F Meng","year":"2014","unstructured":"Meng F, Onori P, Hargrove L, Han Y, Kennedy L, Graf A, et al. Regulation of the histamine\/VEGF axis by miR-125b during cholestatic liver injury in mice. Am J Pathol. 2014;184:662\u201373.","journal-title":"Am J Pathol"},{"key":"6537_CR44","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3892\/mmr.2015.4606","volume":"13","author":"MH Bao","year":"2016","unstructured":"Bao MH, Li JM, Zhou QL, Li GY, Zeng J, Zhao J, et al. Effects of miR\u2011590 on oxLDL\u2011induced endothelial cell apoptosis: roles of p53 and NF\u2011\u03baB. Mol Med Rep. 2016;13:867\u201373.","journal-title":"Mol Med Rep"},{"key":"6537_CR45","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/hep.31176","volume":"72","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liu H, Yin M, Pei X, Hausser A, Ishikawa E, et al. Deletion of protein kinase D3 promotes liver fibrosis in mice. Hepatology. 2020;72:1717\u201334.","journal-title":"Hepatology"},{"key":"6537_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2022.04.004","volume":"106","author":"X Zhou","year":"2022","unstructured":"Zhou X, Lu J, Wu B, Guo Z. HOXA11-AS facilitates the proliferation, cell cycle process and migration of keloid fibroblasts through sponging miR-188-5p to regulate VEGFA. J Dermatol Sci. 2022;106:111\u20138.","journal-title":"J Dermatol Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06537-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T17:04:53Z","timestamp":1713805493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["6537"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-06537-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The human tissues used in this study were approved by the Ethics Committee of the 2nd Xiangya Hospital, Central South University. All samples were accessed with the informed consent of patients. Animal experiments were approved by the Animal Care Committee of the University of Rochester School of Medicine and Dentistry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"283"}}